$2.91
0.031.04%
At close: -
$2.86
-0.05-1.72%
After Hours: 9:29 AM EDT
Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $-0.94 | $0 | -100.0 % |
Q2 | 2024-08-16 | $-9.94 | $-7.40 | -34.3 % |
Q1 | 2024-05-20 | $-40.00 | $-160.00 | 75.0 % |
Q4 | 2024-03-28 | $-120.00 | $-60.00 | -100.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $8.44M | $11.80M | -28.5 % |
Q2 | 2024-08-16 | $9.30M | $9.00M | 3.37 % |
Q1 | 2024-05-20 | $7.54M | $7.00M | 7.73 % |
Q4 | 2024-03-28 | $7.68M | $6.10M | 25.9 % |
Sunshine Biopharma (SBFM) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $-0.94, which missed the estimate of $0.00.
The Actual Revenue was $8.4M, which missed the estimate of $11.8M.
Browse earnings estimates, EPS, and revenue on all stocks.